Stryker (NYSE:SYK) Capex-to-Operating-Income

: 0.16 (As of Jun. 2023)

View and export this data going back to 1988. Start your Free Trial

Capex-to-Operating-Income measures a company's investments in physical assets such as property, industrial buildings or equipment to its operating income.

Stryker's Capital Expenditure for the three months ended in Jun. 2023 was $-152.00 Mil. Its Operating Income for the three months ended in Jun. 2023 was $968.00 Mil.

Hence, Stryker's Capex-to-Operating-Income for the three months ended in Jun. 2023 was 0.16.

Stryker Capex-to-Operating-Income Historical Data

The historical data trend for Stryker's Capex-to-Operating-Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stryker Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Capex-to-Operating-Income

0.22

0.20

0.19

Stryker Quarterly Data
	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
Capex-to-Operating-Income																0.18	0.17	0.19	0.18	0.16

Competitive Comparison

For the Medical Devices subindustry, Stryker's Capex-to-Operating-Income, along with its competitors' market caps and Capex-to-Operating-Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Annual Data Quarterly Data

Stryker Capex-to-Operating-Income Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Stryker's Capex-to-Operating-Income distribution charts can be found below:

* The bar in red indicates where Stryker's Capex-to-Operating-Income falls in comparison to its industry or sector. The grey bar indicates the Capex-to-Operating-Income's extreme value range as defined by GuruFocus.

Stryker Capex-to-Operating-Income Calculation

Stryker's Capex-to-Operating-Income for the fiscal year that ended in Dec. 2022 is calculated as

Capex-to-Operating-Income	=	- Capital Expenditure	/	Operating Income
	=	- (-588)	/	3042
	=	0.19

Stryker's Capex-to-Operating-Income for the quarter that ended in Jun. 2023 is calculated as

Capex-to-Operating-Income	=	- Capital Expenditure	/	Operating Income
	=	- (-152)	/	968
	=	0.16

Stryker (NYSE:SYK) Capex-to-Operating-Income Explanation

Capex-to-Operating-Income assesses how much emphasis a company is placing upon investing in capital-intensive projects. The ratio is generally a good gauge to quantify how much focus on growth a company has. Typically, smaller companies that are still growing and expanding will have a higher Capex to Operating Income Ratio, since such businesses are likely investing more in physical assets. Lower ratios could indicate that a company has reached maturity and it is no longer pursuing aggressive growth.

Stryker Capex-to-Operating-Income Related Terms

Thank you for viewing the detailed overview of Stryker's Capex-to-Operating-Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Stryker (NYSE:SYK) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Stryker Corp (NYSE:SYK) » Definitions » Capex-to-Operating-Income

Comparable Companies

Traded in Other Exchanges

SYK:Mexico SYK:Germany S1YK34:Brazil SYK:Austria

Address

2825 Airview Boulevard, Kalamazoo, MI, USA, 49002

Website

https://www.stryker.com

Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and spinal devices. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Just over one fourth of Stryker's total revenue currently comes from outside the United States.

Executives

James Andrew Pierce	officer: Group President	2825 AIRVIEW BLVD, KALAMAZOO MI 49002
Spencer S Stiles	officer: Group President	2825 AIRVIEW BLVD, KALAMAZOO MI 49002
Giovanni Caforio	director	BRISTOL-MYERS SQUIBB COMPANY, ROUTE 206 & PROVINCELINE ROAD, LAWRENCEVILLE NJ 08543
Skeete Tatum Lisa M	director	2825 AIRVIEW BLVD, KALAMAZOO MI 49002
Robert S Fletcher	officer: VP, Chief Legal Officer	2825 AIRVIEW BOULEVARD, KALAMAZOO MI 49002
Viju Menon	officer: Group President	2825 AIRVIEW BLVD, KALAMAZOO MI 49002
Sherilyn S Mccoy	director	JOHNSON & JOHNSON, ONE JOHNSON & JOHNSON PLAZA, NEW BRUNSWICK NJ 08933
Rajeev Suri	director	2825 AIRVIEW BLVD, KALAMAZOO MI 49002
Mary K Brainerd	director	8170 33RD AVENUE SOUTH, BLOOMINGTON MN 55425
Graham A Mclean	officer: President, Asia-Pacific	1 CORPORATE AVENUE ROWVILLE, VICTORIA C3 3178
Glenn S Boehnlein	officer: Vice President, CFO	2825 AIRVIEW BLVD, KALAMAZOO MI 49002
M Kathryn Fink	officer: VP, Global Human Resources	2825 AIRVIEW BLVD, KALAMAZOO MI 49002
Yin C Becker	officer: VP, Comm. & Public Affairs	2825 AIRVIEW BLVD, KALAMAZOO MI 49002
Bijoy Sagar	officer: VP, Chief Information Officer	2825 AIRVIEW BLVD, KALAMAZOO MI 49002
Michael Damon Hutchinson	officer: General Counsel	2825 AIRVIEW BLVD, KALAMAZOO MI 49002